CAS 33184-16-6 - China Factory, Suppliers, Manufacturers

CAS 33184-16-6, , , ,. The product will supply to all over the world, such as Europe, America, Australia,, ,, .

Related Products

5-Fluoro-2-Methylbenzoic Acid CAS 33184-16-6 Assay ≥98.0% Rucaparib Intermediate
Read More

Trimagnesium Dicitrate Nonahydrate CAS 153531-96-5 Magnesium (Mg) 14.5%~16.4%

Saccharin Insoluble CAS 81-07-2 Purity >99.0% (HPLC)

2,3-Butanedione CAS 431-03-8 Purity >99.0% (GC)

Citric Acid Anhydrous CAS 77-92-9 Assay 99.5~100.5%

Dimethyl Dicarbonate (DMPC) CAS 4525-33-1 Purity ≥99.8% (HPLC) Food Additive Preservative

Maltol CAS 118-71-8 (3-Hydroxy-2-Methyl-4-Pyrone) Purity ≥99.0% (HPLC)

Top Selling Products

Related Blog
Reviews

Method Of Analyzing Palladium Content In Palladium Catalysts

1. Abstract Enrichment palladium of palladium catalysts by pyrometallurgy, then dissolve the palladium in admixture acid, the liquid is analyzed by AAS. 2. Reagent 2.1 Hydrochloric acid(ρ1.19g/ml) ...
The Third Conference on Boron Chemistry of Chinese Chemical Society，CCS-CBS-III

The Third Conference on Boron Chemistry of Chinese Chemical Society (CCS-CBS) will be held in Suzhou, Jiangsu Province from October 15 to 18, 2021. This conference will be hosted by Inorganic Chemi...
Xi presents award to top scientists

President Xi Jinping, also general secretary of the Communist Party of China (CPC) Central Committee and chairman of the Central Military Commission, presents China’s top science award to a...
Pfizer's Novel COVID-19 Oral Antiviral Treatment Candidate Reduced Risk Of Hospitalization Or Death By 89% In Interim Analysis Of Phase 2/3 EPIC-HR Study

Friday, November 05, 2021 – 06:45am PAXLOVID™ (PF-07321332; ritonavir) was found to reduce the risk of hospitalization or death by 89% compared to placebo in non-hospitalized high-risk adult...
Paxlovid: what we know about Pfizer's Covid-19 pill

Pfizer is seeking emergency use authorisation from the FDA for its novel Covid-19 antiviral pill Paxlovid. Share Article On the heels of Merck antiviral molnupiravir’s UK approval, Pfizer...
New COVID treatments offer hope

Scientists around the world have made promising breakthroughs in developing a cure for COVID-19. Among new developments include antiviral pills and antibody compounds. As more countries look to ado...

2022.11.01 19:04:59
2022.10.01 06:23:49
2022.07.18 17:22:57
2022.07.11 08:45:23
2022.05.08 03:49:57
2021.10.29 06:29:02

CAS 33184-16-6 - China Factory, Suppliers, Manufacturers

Related Products

5-Fluoro-2-Methylbenzoic Acid CAS 33184-16-6 Assay ≥98.0% Rucaparib Intermediate

Trimagnesium Dicitrate Nonahydrate CAS 153531-96-5 Magnesium (Mg) 14.5%~16.4%

Saccharin Insoluble CAS 81-07-2 Purity >99.0% (HPLC)

2,3-Butanedione CAS 431-03-8 Purity >99.0% (GC)

Citric Acid Anhydrous CAS 77-92-9 Assay 99.5~100.5%

Dimethyl Dicarbonate (DMPC) CAS 4525-33-1 Purity ≥99.8% (HPLC) Food Additive Preservative

Maltol CAS 118-71-8 (3-Hydroxy-2-Methyl-4-Pyrone) Purity ≥99.0% (HPLC)

Top Selling Products

4'-Methylacetophenone CAS 122-00-9 Purity >98.0% (GC)

DIC CAS 693-13-0 N,N'-Diisopropylcarbodiimide Coupling Reagent Purity >99.0% (GC) Factory

4-Bromo-2-Fluorobenzoic Acid CAS 112704-79-7 Purity ≥99.0% (HPLC) Factory

2-Chloroquinoline CAS 612-62-4 Purity >98.0% (GC)

3-Fluorothiophenol CAS 2557-77-9 Purity >99.0% (GC) Factory

4-Nitrobenzyl Bromide CAS 100-11-8 Purity >99.0% (HPLC)

Boc-Phe(3-CN)-OH CAS 131980-30-8 Boc-3-Cyano-L-Phenylalanine Purity >98.0% (HPLC)

Ethyl 2-Bromoisobutyrate CAS 600-00-0 Purity >98.0% (GC) High Quality

2-Hydroxy-3-Nitropyridine CAS 6332-56-5 Purity ≥99.0% (HPLC) Factory

3-Bromo-7-Azaindole CAS 74420-15-8 Purity >98.0% (GC) Factory High Purity

(R)-(-)-2-Amino-1-butanol CAS 5856-63-3 Purity (Chemical Titration) ≥98.0% Assay (GC) ≥99.0% High Purity

Boc-L-Tryptophanol CAS 82689-19-8 Boc-Trp-Ol Purity >98.0% (HPLC)

Method Of Analyzing Palladium Content In Palladium Catalysts

The Third Conference on Boron Chemistry of Chinese Chemical Society，CCS-CBS-III

Xi presents award to top scientists

Pfizer's Novel COVID-19 Oral Antiviral Treatment Candidate Reduced Risk Of Hospitalization Or Death By 89% In Interim Analysis Of Phase 2/3 EPIC-HR Study

Paxlovid: what we know about Pfizer's Covid-19 pill

New COVID treatments offer hope

2022.11.01 19:04:59

2022.10.01 06:23:49

2022.07.18 17:22:57

2022.07.11 08:45:23

2022.05.08 03:49:57

2021.10.29 06:29:02

related search